Proto-oncogene Bmi-1 and head and neck cancer

[1]

Guo Zehao, Zhang Junwang. Role of PFDN and its subunits in tumorigenesis and tumor development [J]. Journal of International Oncology, 2024, 51(6): 350-353.

[2]

Chen Qi, Xu Chenyang, Wang Yin, Lei Dapeng. Current application status of hyperspectral imaging in the diagnosis and treatment of head and neck tumor [J]. Journal of International Oncology, 2024, 51(5): 298-302.

[3]

Liu Xiaodi, Su Jianfei, Zhang Jingxian, Wei Xueqin, Jia Yingjie. Research progress of myeloid-derived suppressor cells in tumor angiogenesis [J]. Journal of International Oncology, 2024, 51(1): 50-54.

[4]

Ye Tongtong, Wu Zeyu, Xi Wenyi, Wang Zhiwei, Jiang Xiaochun, Zhao Chenhui. Role of ABRACL in the occurrence and development of malignant tumors [J]. Journal of International Oncology, 2023, 50(9): 544-547.

[5]

[6]

Chen Xinyi, Weng Yiming, Wei Jiayan, Wang Jinsong, Peng Min. Advances in immune checkpoint inhibitors in the treatment of recurrent or metastatic head and neck squamous cell carcinoma [J]. Journal of International Oncology, 2023, 50(9): 553-557.

[7]

[8]

Zhang Yuan, Bai Zhiyu, Li Qi, Feng Qinmei. Current status of research on exosomes in malignancies [J]. Journal of International Oncology, 2023, 50(8): 484-488.

[9]

Ju Yifan, Xu Chenyang, Lei Dapeng. Research progress of pathomics in head and neck neoplasms [J]. Journal of International Oncology, 2023, 50(5): 294-298.

[10]

[11]

[12]

Chen Yi, Han Liang, Cai Li. Multivariate analysis of chemotherapy induced oral mucositis in patients with head and neck tumors [J]. Journal of International Oncology, 2022, 49(9): 521-525.

[13]

Li Lixi, Wen Tingyu, Guan Xiuwen, Zhai Jingtong, Ma Fei. Genetic susceptibility genes and clinical features of early-onset breast cancer [J]. Journal of International Oncology, 2022, 49(4): 206-209.

[14]

Zeng Yan, Luo Pan, Wang Ziqi, Wu Weili. Mechanism of drug induced ferroptosis in the treatment of head and neck tumors [J]. Journal of International Oncology, 2022, 49(3): 173-176.

[15]

Lao Zheng, Tu Wenyong, Xu Xuanli, Zhang Lin, Shao Ziyang, Shi Huifeng. Nimotuzumab combined with definitive radiotherapy for inoperable locally advanced oral and maxillofacial squamous cell carcinoma [J]. Journal of International Oncology, 2022, 49(11): 665-670.

PDF